Profile | GDS5420 / 222267_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 43.04 | 29 |
GSM1296119 | B_lesional_pre-dose | 274.86 | 57 |
GSM1296076 | C_lesional_pre-dose | 151.38 | 49 |
GSM1296092 | D_lesional_pre-dose | 109.12 | 45 |
GSM1296103 | E_lesional_pre-dose | 50.55 | 32 |
GSM1296078 | F_lesional_pre-dose | 208.27 | 55 |
GSM1296107 | G_lesional_pre-dose | 299.47 | 59 |
GSM1296109 | H_lesional_pre-dose | 242.51 | 54 |
GSM1296080 | I_lesional_pre-dose | 14.79 | 15 |
GSM1296090 | J_lesional_pre-dose | 97.65 | 42 |
GSM1296074 | K_lesional_pre-dose | 88.8 | 42 |
GSM1296111 | L_lesional_pre-dose | 366.66 | 62 |
GSM1296099 | M_lesional_pre-dose | 63.6 | 34 |
GSM1296086 | O_lesional_pre-dose | 108.52 | 44 |
GSM1296117 | P_lesional_pre-dose | 353.82 | 61 |
GSM1296113 | Q_lesional_pre-dose | 321.12 | 59 |
GSM1296096 | R_lesional_pre-dose | 44.38 | 30 |
GSM1296105 | S_lesional_pre-dose | 52.19 | 31 |
GSM1296098 | T_lesional_pre-dose | 43.31 | 26 |
GSM1296101 | U_lesional_pre-dose | 20.48 | 18 |
GSM1296121 | V_lesional_pre-dose | 223.81 | 54 |
GSM1296088 | W_lesional_pre-dose | 99.47 | 42 |
GSM1296082 | X_lesional_pre-dose | 158.9 | 50 |
GSM1296115 | Y_lesional_pre-dose | 279.43 | 58 |
GSM1296084 | Z_lesional_pre-dose | 87.53 | 39 |
GSM1296072 | B_lesional_day8 | 156.16 | 47 |
GSM1296069 | L_lesional_day8 | 330.65 | 60 |
GSM1296071 | P_lesional_day8 | 272.66 | 56 |
GSM1296070 | Y_lesional_day8 | 235.64 | 54 |
GSM1296073 | V_lesional_day8 | 194.05 | 52 |
GSM1296034 | A_lesional_day15 | 42.58 | 28 |
GSM1296041 | G_lesional_day15 | 321.15 | 60 |
GSM1296035 | R_lesional_day15 | 27.53 | 25 |
GSM1296038 | U_lesional_day15 | 56.24 | 33 |
GSM1296047 | B_lesional_day15 | 201.27 | 51 |
GSM1296039 | E_lesional_day15 | 69.19 | 36 |
GSM1296042 | H_lesional_day15 | 256.42 | 56 |
GSM1296043 | L_lesional_day15 | 271.06 | 56 |
GSM1296037 | M_lesional_day15 | 46.2 | 28 |
GSM1296046 | P_lesional_day15 | 333.85 | 60 |
GSM1296044 | Q_lesional_day15 | 311.08 | 58 |
GSM1296045 | Y_lesional_day15 | 280.78 | 57 |
GSM1296025 | C_lesional_day15 | 37.04 | 26 |
GSM1296033 | D_lesional_day15 | 72.96 | 37 |
GSM1296027 | I_lesional_day15 | 84.87 | 41 |
GSM1296032 | J_lesional_day15 | 53.85 | 32 |
GSM1296024 | K_lesional_day15 | 47.4 | 31 |
GSM1296031 | W_lesional_day15 | 75.17 | 36 |
GSM1296028 | X_lesional_day15 | 71.49 | 37 |
GSM1296029 | Z_lesional_day15 | 142.82 | 47 |
GSM1296026 | F_lesional_day15 | 64.5 | 35 |
GSM1296030 | O_lesional_day15 | 63.17 | 37 |
GSM1296040 | S_lesional_day15 | 25.31 | 20 |
GSM1296036 | T_lesional_day15 | 45.03 | 28 |
GSM1296048 | V_lesional_day15 | 175.5 | 50 |
GSM1296059 | A_lesional_day43 | 19.8 | 19 |
GSM1296066 | G_lesional_day43 | 312.48 | 59 |
GSM1296060 | R_lesional_day43 | 73.12 | 37 |
GSM1296063 | U_lesional_day43 | 99.24 | 41 |
GSM1296064 | E_lesional_day43 | 77.95 | 38 |
GSM1296067 | H_lesional_day43 | 131.03 | 43 |
GSM1296062 | M_lesional_day43 | 26.88 | 23 |
GSM1296068 | Q_lesional_day43 | 282.09 | 56 |
GSM1296050 | C_lesional_day43 | 95.47 | 40 |
GSM1296057 | D_lesional_day43 | 39.45 | 28 |
GSM1296052 | I_lesional_day43 | 70.23 | 38 |
GSM1296054 | J_lesional_day43 | 52.89 | 31 |
GSM1296049 | K_lesional_day43 | 50.64 | 31 |
GSM1296055 | W_lesional_day43 | 42.09 | 28 |
GSM1296053 | X_lesional_day43 | 45.43 | 30 |
GSM1296058 | Z_lesional_day43 | 27.4 | 24 |
GSM1296051 | F_lesional_day43 | 165.24 | 50 |
GSM1296056 | O_lesional_day43 | 35.52 | 28 |
GSM1296065 | S_lesional_day43 | 65.71 | 35 |
GSM1296061 | T_lesional_day43 | 29.37 | 22 |
GSM1296095 | A_non-lesional_pre-dose | 42.91 | 29 |
GSM1296120 | B_non-lesional_pre-dose | 217.46 | 53 |
GSM1296077 | C_non-lesional_pre-dose | 100.23 | 42 |
GSM1296093 | D_non-lesional_pre-dose | 65.18 | 34 |
GSM1296104 | E_non-lesional_pre-dose | 70.83 | 36 |
GSM1296079 | F_non-lesional_pre-dose | 80.01 | 38 |
GSM1296108 | G_non-lesional_pre-dose | 200.29 | 51 |
GSM1296110 | H_non-lesional_pre-dose | 270.94 | 56 |
GSM1296081 | I_non-lesional_pre-dose | 43.44 | 31 |
GSM1296091 | J_non-lesional_pre-dose | 146.15 | 48 |
GSM1296075 | K_non-lesional_pre-dose | 97.93 | 42 |
GSM1296112 | L_non-lesional_pre-dose | 303.51 | 58 |
GSM1296100 | M_non-lesional_pre-dose | 38.94 | 27 |
GSM1296087 | O_non-lesional_pre-dose | 102.77 | 44 |
GSM1296118 | P_non-lesional_pre-dose | 314.62 | 59 |
GSM1296114 | Q_non-lesional_pre-dose | 331.57 | 60 |
GSM1296097 | R_non-lesional_pre-dose | 36.92 | 27 |
GSM1296106 | S_non-lesional_pre-dose | 74.86 | 36 |
GSM1296102 | U_non-lesional_pre-dose | ||
GSM1296122 | V_non-lesional_pre-dose | 107.54 | 40 |
GSM1296089 | W_non-lesional_pre-dose | 82.01 | 37 |
GSM1296083 | X_non-lesional_pre-dose | 36.58 | 27 |
GSM1296116 | Y_non-lesional_pre-dose | 331.32 | 60 |
GSM1296085 | Z_non-lesional_pre-dose | 59.81 | 34 |